GVHD and the Cornea: What Patients Need to Know

A slit lamp is a specialized microscope that uses a thin, bright beam of light to examine each layer of the cornea and surrounding eye structures. Your provider will apply small amounts of dye to highlight surface damage, check for early erosions, and look for signs of conjunctival scarring. This exam gives a clear picture of how far surface damage has progressed.

Several quick tests measure how well your tear glands are working. A small strip of paper placed under the lower eyelid measures fluid production. A dye test shows how quickly the tear film breaks apart on the eye surface. Blink rate and the ability to fully close the eyelids are also evaluated. Low scores across these tests support a diagnosis of eye GVHD.

When more detailed information is needed, imaging tools provide a closer look. Pachymetry measures corneal thickness, which helps identify thinning before it becomes dangerous. Optical coherence tomography (OCT) maps the individual layers of the cornea in detail. These images are also used to track changes over time and guide treatment decisions.

Eye GVHD is part of a larger medical picture. Your eye care provider will communicate regularly with your transplant team and other specialists involved in your care. This coordination helps ensure that eye drops and body-wide medications are working together rather than at cross-purposes during a flare.

Acute GVHD can produce eye symptoms within the first few weeks after transplant, though it more often appears within the first three months. Chronic GVHD eye involvement tends to develop months to years after transplant and can appear even when acute GVHD was mild or well controlled. A baseline eye exam shortly after transplant provides a reference point that makes it easier to detect changes later.

Redness-relief drops should be avoided in eye GVHD. They work by constricting blood vessels, and with regular use they can cause rebound redness and further irritate a compromised eye surface. Preservative-free artificial tears are a much safer choice for frequent daily use. Always check with your eye care provider before starting any new over-the-counter product, since some formulations can interfere with prescription drops you are already using.

For many patients, eye GVHD is a long-term condition that requires ongoing management rather than a temporary one that resolves fully. Some patients see meaningful improvement as systemic GVHD is brought under better control. Others need sustained treatment with drops, scleral lenses, or other therapies for years. The goal of care is to keep the cornea healthy and maintain functional vision, even if dry eye symptoms remain.

Scleral lenses do require a learning period, and most patients become comfortable inserting and removing them within a few sessions with guidance from a specialist. Because they create a fluid-filled space between the lens and the cornea, they often provide noticeably better comfort than soft contact lenses for patients with severe dry eye. Proper fit and regular follow-up care are essential to get the most benefit and avoid complications.

Most patients are able to continue working and driving with appropriate treatment in place. Using drops before tasks that require sustained focus, taking regular visual breaks, and wearing anti-glare lenses in bright conditions can all help. If your vision fluctuates significantly throughout the day, discuss this specifically with your eye care provider, as it may indicate that your current treatment plan needs adjustment.

Plan ahead by requesting refills before any trip and carrying an extra supply in your carry-on luggage if flying. If you run out unexpectedly, contact your eye care provider right away so they can send a prescription to a nearby pharmacy. Do not substitute a different product without guidance. Stopping prescription drops abruptly during a period of active disease can allow inflammation to worsen quickly.